You are here
Final decisions amending, or not amending, the current Poisons Standard, April 2018
Scheduling medicines and poisons
Part A - Final decisions on matters referred to an expert advisory committee (November 2017)
2. Joint meeting of the Advisory Committee on Chemicals and Medicines Scheduling (ACCS/ACMS #17)
Delegate's final decision
The delegate's final decision is to create a new Schedule 4 entry for cimicoxib as follows:
Schedule 4 - New Entry
Implementation date: 1 June 2018
As no new evidence has been received to alter the interim decision for cimicoxib, the delegate has confirmed that the final decision and reasons for the final decision are identical to the interim decision.
Public submissions on the interim decision
No submissions were received.
The interim decision for cimicoxib was published on the TGA website on 5 February 2018 at Scheduling delegates' interim decisions and invitation for further comment: ACCS/ACMS, November 2017 - 2.4. Cimicoxib.
The pre-meeting scheduling proposal for cimicoxib was published on the TGA website on 6 September 2017 at Consultation: Proposed amendments to the Poisons Standard - ACCS, ACMS and Joint ACCS/ACMS meetings, November 2017.